December 2021 - Page 4 of 8 - CannabisNewsWire

ThursdayDec 16, 2021 11:46 am

Marijuana Company of America Inc. (MCOA) Achieving Growth Through Acquisitions and Strategic Partnerships

MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021 MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal cannabis and industrial hemp sectors The company continues to forge these partnerships to diversify its product and services line and provide consistent value to its shareholders Marijuana Company of America (OTC: MCOA) released financial results for the three months ended September 30, 2021 (“Q3 2021”),…

ThursdayDec 16, 2021 10:51 am

Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Introduces New Dry Herb Consumer Products; Issues 2022 Revenue Guidance of $35-45 Million

Flora Growth’s subsidiary, Vessel Brand, recently introduced new products for dry herb consumption and anticipates releasing additional products in 2022 FLGC acquired Vessel in a transaction that closed in November Founded in 2018, Vessel is an industry leader in the cannabis consumer technology and accessories space Flora Growth also announced a 2022 revenue guidance of $35-45 million CEO Luis Merchan held a webinar on December 14 in which he highlighted the company’s 2021 operational performance, commented on the revenue guidance, and fielded questions Flora Growth (NASDAQ: FLGC), an internationally focused company committed to delivering the most compelling customer experiences in…

ThursdayDec 16, 2021 4:20 am

420 with CNW — Patients, Doctors Now Discussing Medical Marijuana

Cannabis has always been a controversial topic. Even as dozens of states passed medical cannabis regulations and more studies found that the plant had plenty of medical potential, the stigma around cannabis remained. Not only did this prevent important conversations surrounding topics such as the disproportionate effects of cannabis prohibition from happening early enough, but it also kept patients from talking about cannabis with their doctors, even if they stood to benefit a great deal from marijuana-based treatment. However, results from a new survey indicate that this may be changing. Healthcare company Cannaceutica conducted a survey of 445 healthcare providers…

WednesdayDec 15, 2021 4:20 pm

420 with CNW — Four Marijuana Products That May Offer Relief from PMS Symptoms

Periods usually affect women differently. While some feel discomfort, a huge number experience rough periods, enduring debilitating pain as well as symptoms such as abdominal pressure, muscle aches, nausea and more. Premenstrual syndrome (“PMS”) is a group of symptoms that occur between ovulation and periods. It manifests in various symptoms and signs, which include irritability, fatigue, food cravings, tender breasts, mood swings and depression. Research has shown that marijuana possesses medicinal benefits that are effective in the management of pain. Did you know, however, that it can also be used to obtain relief from premenstrual syndrome? The marijuana industry has…

WednesdayDec 15, 2021 4:20 am

420 with CNW — VA Researcher Shares Cannabis Insights, Study Results during Latest Podcast

In a new podcast, a researcher from the Department of Veterans’ Affairs stated that individuals suffering from PTSD who use cannabis experience fewer symptoms of the disorder and recover more quickly than individuals who don’t. The forensic neuro-psychiatrist, Hal Wortzel, discussed the findings of an observational study he’d carried out during the podcast. This is in addition to talking about how the ongoing federal prohibition on cannabis has hindered research from progressing. To learn how marijuana affects post-traumatic stress disorder, the team of researchers, led by Wortzel, tracked two groups comprising of 150 individuals living with the condition. Of this…

TuesdayDec 14, 2021 4:20 pm

420 with CNW — Bill to Remove Regulatory Grey Area for CBD in Drinks, Supplements Filed in Congress

Although CBD has been legal since the 2018 farm bill legalized the cultivation and growth of industrial hemp and its derivatives, the young industry is largely unregulated. Hemp stakeholders have urged the federal government to craft comprehensive regulations for CBD as sales of CBD-infused products ramp up, but the responsible agencies have dragged their feet. As a result, the cannabidiol industry has attracted plenty of dishonest entities that have flooded the market with subpar CBD products which can even put consumers’ health at risk. After years of back and forth, a bill that would remove the regulatory gray area for…

TuesdayDec 14, 2021 1:17 pm

NCIA Presents 7th Annual Cannabis Business Summit & Expo

Venue: San Francisco, CA Date: December 15 - 17, 2021 Founded in 2010, the National Cannabis Industry Association (“NCIA”) is the oldest, largest, and most effective trade association representing the legal cannabis business. It is committed to promoting the growth of a responsible, sustainable, and inclusive cannabis industry, and works towards a favorable social, economic, and regulatory environment throughout the United States. NCIA’s 7th Annual Cannabis Business Summit & Expo will be held at the Moscone Center in San Francisco, California, from December 15-17, 2021. Throughout the three-day event, cannabis industry leaders and advocates Troy Datcher, Calvin Johnson, Jr., Rachael…

TuesdayDec 14, 2021 1:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Participates in the Benzinga Global Small Cap Conference; Committed to Innovation and Improving Quality of Life

Lexaria presented at this year’s Benzinga Global Small Cap Conference held on December 8-9, 2021 The event came right after the company announced human clinical hypertension study HYPER-H21-4, its most ambitious one yet Lexaria plans to sublicense its patented DehydraTECH(TM) technology worldwide, allowing for more people to benefit from it Going into 2022, the company looks forward to reporting on results from its HYPER-H21-3 clinical study and receiving Independent Review Board (“IRB”) approval for its HYPER-H21-4 study Lexaria Bioscience (NASDAQ: LEXX) just participated in this year’s Benzinga Global Small Cap Conference. The two-day event was a showcase for small cap…

TuesdayDec 14, 2021 4:20 am

420 with CNW — California Starts Process to Standardize Marijuana Testing

Regulators in the state of California have begun to standardize marijuana testing as mandated by a new law in the state. The objective of this is to eliminate inconsistencies observed in operational cannabis laboratories in the state. Advocates believe that the law will improve reliability and quality as well as discourage laboratory shopping and other practices that produce inauthentic test results. Officials involved in the industry claim that some cannabis businesses look for labs that will produce the results they’d like to see with regard to contaminants and THC potency. Critics also assert that the absence of standards is also…

MondayDec 13, 2021 4:20 pm

420 with CNW — Hemp or Cannabis: Does the CBD Source Matter?

The past few years have seen cannabidiol (“CBD”) grow from an obscure product that was only known to niche consumers to a worldwide phenomenon worth billions of dollars. This was partly thanks to the 2018 farm bill, which legalized industrial hemp and its derivatives after decades of prohibition, and partly to growing reports of CBD’s medical potential. Despite cannabidiol’s growing popularity, however, plenty of people don’t actually know what CBD is or where it comes from. CBD is one of more than 100 chemical compounds that are produced by the cannabis plant called cannabinoids. What we call industrial hemp is…